Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b

a technology of carboxamide and derivatives, applied in the field of carboxamide derivatives, can solve the problems of lack of selectivity, poor efficacy, and limited direct treatment options

Inactive Publication Date: 2017-06-08
JANSSEN SCI IRELAND UC
View PDF1 Cites 19 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

An effective and well-tolerated vaccine exists, but direct treatment options are currently limited to interferon and the following antivirals; tenofovir, lamivudine, adefovir, entecavir and telbivudine.
Amongst the problems which HBV direct antivirals may encounter are toxicity, mutagenicity, lack of selectivity, poor efficacy, poor bioavailability, and difficulty of synthesis.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
  • Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
  • Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0011]The present invention relates to a compound of Formula (I)

[0012]or a stereoisomer or tautomeric form thereof, wherein:

[0013]represents

[0014]each of Ra, Rb, Rc, Rd, Re, Rf and Rg are independently selected from the group consisting of Hydrogen and methyl;[0015]Rh is Hydrogen;[0016]Ri is Hydrogen;[0017]R1, R2and R3 are independently selected from the group consisting of Hydrogen, Fluoro, Chloro, Bromo, —CHF2, —CH2F, —CF3, —CN and methyl;[0018]R6 is selected from the group consisting of C1-C6alkyl and a 3-7 membered saturated ring optionally containing one or more heteroatoms each independently selected from the group consisting of O, S and N, such C1-C6alkyl or 3-7 membered saturated ring optionally substituted with one or more substituents selected from the group consisting of Fluoro, C1-C3alkyl optionally substituted with one or more Fluoro, —CN, OH;[0019]R7 represents hydrogen;

[0020]or a pharmaceutically acceptable salt or a solvate thereof.

[0021]The invention further relates...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
temperatureaaaaaaaaaa
melting pointaaaaaaaaaa
Login to view more

Abstract

Inhibitors of HBV replication of formula (I)including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein X, R1 to R7 have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.

Description

BACKGROUND ART[0001]The Hepatitis B virus (HBV) is an enveloped, partially double-stranded DNA (dsDNA) virus of the Hepadnavirus family (Hepadnaviridae). Its genome contains 4 overlapping reading frames: the precore / core gene; the polymerase gene; the L, M, and S genes, which encode for the 3 envelope proteins; and the X gene.[0002]Upon infection, the partially double-stranded DNA genome (the relaxed circular DNA; rcDNA) is converted to a covalently closed circular DNA (cccDNA) in the nucleus of the host cell and the viral mRNAs are transcribed. Once encapsidated, the pregenomic RNA (pgRNA), which also codes for core protein and Pol, serves as the template for reverse transcription, which regenerates the partially dsDNA genome (rcDNA) in the nucleocapsid.[0003]HBV has caused epidemics in parts of Asia and Africa, and it is endemic in China. HBV has infected approximately 2 billion people worldwide of which approximately 350 million people have developed chronic infections. The virus...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): C07D207/16C07D211/60A61K45/06A61K31/4025A61K31/445C07D405/12A61K31/40
CPCC07D207/16C07D405/12C07D211/60A61K45/06A61K31/4025A61K31/445A61K31/40C07D207/09C07D211/34A61K2300/00A61P1/16A61P31/20A61P43/00
Inventor VANDYCK, KOENHACHE, GEERWIN YVONNE PAULKESTELEYN, BART RUDOLF ROMANIERABOISSON, PIERRE JEAN-MARIE BERNARD
Owner JANSSEN SCI IRELAND UC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap